Abstract A252: A phase 1 study of ARRY-382, an oral inhibitor of colony-stimulating factor-1 receptor (CSF1R), in patients with advanced or metastatic cancers
Bendell, Johanna C., Tolcher, Anthony W., Jones, Suzanne F., Beeram, Muralidhar, Infante, Jeffrey R., Larsen, Paul, Rasor, Kevin, Garrus, Jennifer E., Li, Jinfang, Cable, P. Louann, Eberhardt, Christine, Schreiber, Jennifer, Rush, Selena, Wood, Kenneth W., Barrett, Emma, Patnaik, Amita
Published in Molecular cancer therapeutics (01.11.2013)
Published in Molecular cancer therapeutics (01.11.2013)
Get full text
Journal Article
A phase 1b study of combined angiogenesis blockade with nesvacumab, a selective monoclonal antibody (MAb) to angiopoietin-2 (Ang2) and ziv-aflibercept in patients with advanced solid malignancies
Papadopoulos, Kyriakos P., Graham, Donna M., Tolcher, Anthony W., Razak, Albiruni R. A., Patnaik, Amita, Bedard, Philippe L., Rasco, Drew Warren, Amaya, Alex, Moore, Kathleen N., Konner, Jason A., Matei, Daniela, Martin, Lainie P., Adriaens, Lieve, Brownstein, Carrie M., Lowy, Israel, Gao, Bo, Kostic, Ana, DiCioccio, A Thomas, Trail, Pamela, Siu, Lillian L.
Published in Journal of clinical oncology (20.05.2014)
Published in Journal of clinical oncology (20.05.2014)
Get full text
Journal Article
Treatment of advanced ovarian and endometrial cancer in the phase I setting: A single center experience
Peng, Wei, Tolcher, Anthony W., Papadopoulos, Kyriakos P., Beeram, Muralidhar, Rasco, Drew Warren, White, Allan J., Smith, Lon S., Drengler, Ronald L., Smetzer, Leslie, Mays, Theresa A., Kaiser, Brianne, Arcos, Rebecca, Alvarez, Cathy, Claiborne, Cally, Mangold, Gina L., Wick, Michael Jude, Patnaik, Amita
Published in Journal of clinical oncology (20.05.2014)
Published in Journal of clinical oncology (20.05.2014)
Get full text
Journal Article
Clinical activity of LY2835219, a novel cell cycle inhibitor selective for CDK4 and CDK6, in patients with non-small cell lung cancer
Goldman, Jonathan Wade, Gandhi, Leena, Patnaik, Amita, Rosen, Lee S., Hilton, John Frederick, Papadopoulos, Kyriakos P., Tolaney, Sara M., Beeram, Muralidhar, Rasco, Drew Warren, Myrand, Scott P., Beckmann, Richard P, Kulanthaivel, Palaniappan, Frenzel, Martin, Cronier, Damien, Chan, Edward M., Flaherty, Keith, Wen, Patrick Y., Tolcher, Anthony W., Shapiro, Geoffrey
Published in Journal of clinical oncology (20.05.2014)
Published in Journal of clinical oncology (20.05.2014)
Get full text
Journal Article
LY2835219, a novel cell cycle inhibitor selective for CDK4/6, in combination with fulvestrant for patients with hormone receptor positive (HR+) metastatic breast cancer
Patnaik, Amita, Rosen, Lee S., Tolaney, Sara M., Tolcher, Anthony W., Goldman, Jonathan Wade, Gandhi, Leena, Papadopoulos, Kyriakos P., Beeram, Muralidhar, Rasco, Drew Warren, Myrand, Scott P., Kulanthaivel, Palaniappan, Andrews, Joan M., Frenzel, Martin, Cronier, Damien, Chan, Edward M., Flaherty, Keith, Wen, Patrick Y., Shapiro, Geoffrey
Published in Journal of clinical oncology (20.05.2014)
Published in Journal of clinical oncology (20.05.2014)
Get full text
Journal Article
Abstract 2764: Effect of PNT2258 combinations with docetaxel, dacarbazine, or vemurafenib on the A375 melanoma xenograft
Rodrigueza, Wendi V., Whitehead, Christopher, Mohammad, Ramzi, McGovern, J. Patrick, Wick, Michael J., Rasco, Drew, Tolcher, Anthony W., Bisgaier, Charles L.
Published in Cancer research (Chicago, Ill.) (15.04.2012)
Published in Cancer research (Chicago, Ill.) (15.04.2012)
Get full text
Journal Article
Abstract LB-409: Results of a phase 1, open-label, dose-escalation study evaluating the safety and tolerability of EZN-3042, a survivin mRNA antagonist, administered with or without docetaxel in adult patients with advanced solid tumors or lymphoma
Tolcher, Anthony W., Patnaik, Amita, Papadopoulos, Kyriakos P., Agnew, James, Lokiec, François M., Rezai, Keyvan, Kalambakas, Stacey, Buchbinder, Aby
Published in Cancer research (Chicago, Ill.) (15.04.2011)
Published in Cancer research (Chicago, Ill.) (15.04.2011)
Get full text
Journal Article
Abstract 2749: MP-470, a dual inhibitor of mutant kinases (c-KIT and PDGFRα) and DNA repair protein Rad 51. Final results from a first-in-man single agent study
Tolcher, Anthony W., Choy, Gavin, Joshi, Rajashree, Redkar, Sanjeev, Fine, Gil, Tibes, Raoul
Published in Cancer research (Chicago, Ill.) (15.04.2010)
Published in Cancer research (Chicago, Ill.) (15.04.2010)
Get full text
Journal Article
Phase I Study of Intravenous PI3K Inhibitor Bay 80–6946: Preliminary Activity in Patients with Relapsed Non-Hodgkin Lymphoma (NHL) Treated in an MTD Expansion Cohort
Patnaik, Amita, Ramanathan, Ramesh K, Appleman, Leonard Joseph, Tolcher, Anthony W, Mountz, James M, Beerham, Muralidhar, Weiss, Glen J, Rasco, Drew W, Lotze, Michael T, Toledo, Frederico GS, Oborski, Matthew J, Rajagopalan, Prabhu, Jeffers, Michael, Kelly, Andrea, Genvresse, Isabelle
Published in Blood (16.11.2012)
Published in Blood (16.11.2012)
Get full text
Journal Article
A first-in-human phase I study of the oral p38 MAPK inhibitor LY2228820 dimesylate in patients with advanced cancer
Goetz, Matthew P., Tolcher, Anthony W., Haluska, Paul, Papadopoulos, Kyriakos P., Erlichman, Charles, Beeram, Muralidhar, Lensing, Janet, Rasco, Drew Warren, Molina, Julian R., Arcos, Rebecca, SHI, Peipei, Kulanthaivel, Palaniappan, Pitou, Celine, Mulle, Lynette, Chan, Edward Michael, Patnaik, Amita
Published in Journal of clinical oncology (20.05.2012)
Published in Journal of clinical oncology (20.05.2012)
Get full text
Journal Article
Personalizing cancer treatment of combined targeting of PI3K/AKT and MAPK pathways in advanced cancer patients harboring simultaneous oncogenic alterations in both signaling pathways
Shimizu, Toshio, Tolcher, Anthony W., Papadopoulos, Kyriakos P., Beeram, Muralidhar, Rasco, Drew Warren, Smith, Lon S., Drengler, Ronald L., Gunn, Shelly, Smetzer, Leslie, Mays, Theresa A., Kaiser, Brianne, Wick, Michael Jude, Patnaik, Amita
Published in Journal of clinical oncology (20.05.2012)
Published in Journal of clinical oncology (20.05.2012)
Get full text
Journal Article
Abstract A225: Dose scheduling and efficacy analysis of the SMAC mimetic TL32711 in primary melanoma tumor xenotransplant models
Burns, Jennifer M., Mitsuuchi, Yasuhiro, Chunduru, Srinivas K., Nieves, Francis E., Wick, Michael J., Tolcher, Anthony W., Papadopoulos, Kyriakos, Graham, Martin A., McKinlay, Mark A.
Published in Molecular cancer therapeutics (12.11.2011)
Published in Molecular cancer therapeutics (12.11.2011)
Get full text
Journal Article
Abstract A37: Development of biologics targeting soluble ligands: Novel biomarker and PK-PD analyzes examining free and total ligand profile following treatment with carlumab (anti-CCL2 mAb)
Seetharam, Shobha, Puchalski, Thomas A., McIntosh, Thomas, Chaturvedi, Shalini, Dawkins, Fitzroy, Elsayed, Yusri, Tolcher, Anthony W., Pienta, Kenneth J., de Bono, Johann S., Takimoto, Chris H.
Published in Molecular cancer therapeutics (12.11.2011)
Published in Molecular cancer therapeutics (12.11.2011)
Get full text
Journal Article
Abstract B17: Establishment, characterization and evaluation of a panel of patient-derived colorectal tumor models
Wick, Michael J., Nieves, Francis E., Thangasamy, Amalraj, Tolcher, Anthony W., Patnaik, Amita, Drengler, Ronald L., Smith, Lon S., Garner, Allison M., Mangold, Gina L., Papadopoulos, Kyriakos P.
Published in Molecular cancer therapeutics (12.11.2011)
Published in Molecular cancer therapeutics (12.11.2011)
Get full text
Journal Article
Abstract B120: In vivo evaluation of dovitinib (TKI258) alone and in combination in patient-derived salivary gland tumor models: Identification of a potential treatment for adenoid cystic carcinoma
Wick, Michael J., Nieves, Francis, Estrada, Vanessa, Kelly, Scott, Kaufman, Jeffrey, Moskaluk, Christopher A., Tolcher, Anthony W., Patnaik, Amita, Shi, Michael, Papadopoulos, Kyriakos P.
Published in Molecular cancer therapeutics (12.11.2011)
Published in Molecular cancer therapeutics (12.11.2011)
Get full text
Journal Article
Abstract B125: Identification and characterization of a panel of B-Raf wildtype and mutant patient-derived low passage tumor models
Wick, Michael J., Nieves, Francis E., Thangasamy, Amalraj, Tolcher, Anthony W., Patnaik, Amita, Smith, Lon S., Miller, Alexander, Beeram, Murali, Drengler, Ronald L., Papadopoulos, Kyriakos P.
Published in Molecular cancer therapeutics (12.11.2011)
Published in Molecular cancer therapeutics (12.11.2011)
Get full text
Journal Article
Phase I study of safety and pharmacokinetics (PK) of GDC-0917, an antagonist of inhibitor of apoptosis (IAP) proteins in patients (Pts) with refractory solid tumors or lymphoma
Tolcher, Anthony W., Papadopoulos, Kyriakos P., Patnaik, Amita, Fairbrother, Wayne J., Wong, Harvey, Budha, Nageshwar R., Darbonne, Walter C., Peale, Franklin V., Mamounas, Michael J., Royer-Joo, Stephanie, Yu, Ron, Portera, Chia C., Bendell, Johanna C., Burris, Howard A., Infante, Jeffrey R.
Published in Journal of clinical oncology (20.05.2013)
Published in Journal of clinical oncology (20.05.2013)
Get full text
Journal Article
A first-in-human phase I study of the CDK4/6 inhibitor, LY2835219, for patients with advanced cancer
Shapiro, Geoffrey, Rosen, Lee S., Tolcher, Anthony W., Goldman, Jonathan Wade, Gandhi, Leena, Papadopoulos, Kyriakos P., Tolaney, Sara M., Beeram, Muralidhar, Rasco, Drew Warren, Kulanthaivel, Palaniappan, Li, Qian, Hu, Tianle, Cronier, Damien, Chan, Edward M, Flaherty, Keith, Wen, Patrick Y., Patnaik, Amita
Published in Journal of clinical oncology (20.05.2013)
Published in Journal of clinical oncology (20.05.2013)
Get full text
Journal Article
A randomized, double-blind, placebo (Pbo)-controlled phase III study of ombrabulin plus cisplatin in patients (pts) with advanced-stage soft-tissue sarcoma after failure of anthracycline and ifosfamide chemotherapies
Papai, Zsuzsanna, Tolcher, Anthony W., Italiano, Antoine, Cupissol, Didier, Lopez-Pousa, Antonio, Chawla, Sant P., Bompas, Emmanuelle, Penel, Nicolas, Isambert, Nicolas, Staddon, Arthur P., Thyss, Antoine, Santoro, Armando, Franke, Fabio A., Cohen, Patrick, Le-Guennec, Solenn, Demetri, George D., Blay, Jean-Yves
Published in Journal of clinical oncology (20.05.2013)
Published in Journal of clinical oncology (20.05.2013)
Get full text
Journal Article